Ibex Investors LLC acquired a new position in shares of Masimo Co. (NASDAQ:MASI) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 1,671 shares of the medical equipment provider’s stock, valued at approximately $208,000.

Several other hedge funds have also bought and sold shares of the company. United Services Automobile Association raised its position in shares of Masimo by 0.7% in the 2nd quarter. United Services Automobile Association now owns 71,510 shares of the medical equipment provider’s stock worth $6,983,000 after buying an additional 485 shares during the period. US Bancorp DE raised its position in shares of Masimo by 36.9% in the 2nd quarter. US Bancorp DE now owns 1,980 shares of the medical equipment provider’s stock worth $193,000 after buying an additional 534 shares during the period. Oregon Public Employees Retirement Fund raised its position in shares of Masimo by 3.0% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 18,628 shares of the medical equipment provider’s stock worth $1,819,000 after buying an additional 535 shares during the period. Security Asset Management raised its position in shares of Masimo by 4.4% in the 3rd quarter. Security Asset Management now owns 12,834 shares of the medical equipment provider’s stock worth $1,598,000 after buying an additional 539 shares during the period. Finally, SG Americas Securities LLC raised its position in shares of Masimo by 3.2% in the 3rd quarter. SG Americas Securities LLC now owns 24,081 shares of the medical equipment provider’s stock worth $2,999,000 after buying an additional 756 shares during the period. Institutional investors and hedge funds own 82.74% of the company’s stock.

Shares of MASI opened at $108.04 on Friday. The firm has a market capitalization of $5.74 billion, a P/E ratio of 37.21, a PEG ratio of 2.38 and a beta of 1.07. Masimo Co. has a twelve month low of $80.69 and a twelve month high of $126.89.

Masimo (NASDAQ:MASI) last issued its earnings results on Wednesday, October 31st. The medical equipment provider reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.02. The business had revenue of $210.58 million for the quarter, compared to analyst estimates of $207.62 million. Masimo had a return on equity of 20.29% and a net margin of 17.08%. The business’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period last year, the company posted $0.56 EPS. As a group, analysts predict that Masimo Co. will post 2.92 earnings per share for the current fiscal year.

In other Masimo news, COO Anand Sampath sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $110.00, for a total value of $3,300,000.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Ramshorst David J. Van sold 2,675 shares of the firm’s stock in a transaction dated Monday, September 24th. The shares were sold at an average price of $122.87, for a total value of $328,677.25. Following the completion of the transaction, the insider now directly owns 2,325 shares in the company, valued at $285,672.75. The disclosure for this sale can be found here. Insiders sold 309,180 shares of company stock worth $37,570,849 over the last three months. 12.60% of the stock is currently owned by corporate insiders.

Several research analysts recently weighed in on the company. Needham & Company LLC assumed coverage on Masimo in a research report on Friday, September 14th. They issued a “buy” rating on the stock. BidaskClub raised Masimo from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 17th. Zacks Investment Research lowered Masimo from a “buy” rating to a “hold” rating in a research report on Monday. UBS Group assumed coverage on Masimo in a research report on Tuesday, November 27th. They issued a “buy” rating and a $137.00 target price on the stock. Finally, Piper Jaffray Companies increased their target price on Masimo to $120.00 and gave the stock a “neutral” rating in a research report on Thursday, November 1st. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $119.00.

TRADEMARK VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://www.watchlistnews.com/ibex-investors-llc-invests-208000-in-masimo-co-masi/2667772.html.

Masimo Company Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also: Float

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.